| Literature DB >> 27692175 |
E-L Göttgens1, P N Span1, M M Zegers2.
Abstract
The transformation of polarized epithelial cells into cells with mesenchymal characteristics by the morphogenetic process of epithelial-mesenchymal transition (EMT) is a well-characterized process essential for embryonic development and associated with cancer progression. EMT is a program driven by changes in gene expression induced by several EMT-specific transcription factors, which inhibit the expression of cell-cell adhesion proteins and other epithelial markers, causing a characteristic loss of cell-cell adhesion, a switch to mesenchymal cell morphology, and increased migratory capabilities. Recently, it has become apparent that in addition to these transcriptionally regulated changes, EMT may also be regulated posttranscriptionally, that is, by alternative splicing. Specifically, the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) have been described as epithelial-specific splicing master regulators specifically involved in EMT-associated alternative splicing. Here, we discuss the regulation of ESRP activity, as well as the evidence supporting a causal role of ESRPs in EMT.Entities:
Keywords: ESRP1; ESRP2; alternative splicing; carcinogenesis; cell signaling; epithelial–mesenchymal transition
Mesh:
Substances:
Year: 2016 PMID: 27692175 DOI: 10.1016/bs.ircmb.2016.06.003
Source DB: PubMed Journal: Int Rev Cell Mol Biol ISSN: 1937-6448 Impact factor: 6.813